Nasdaq-Listed Windtree Seeks $520M for BNB Reserve Accumulation
Publicly listed biotechnology company, Windtree Therapeutics, announced plans to secure up to $520 million in funding to expand its BNB crypto reserves. It disclosed that it has entered a Common Stock Purchase Agreement for an equity line of credit (ELOC) of up to $500 million, alongside a separate $20 million stock purchase agreement with Build…
